These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 5084716

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical trial of an hepatobiliary analeptic agent].
    Chapuy H, Jeune M, Sambin P, Girard M.
    J Med Lyon; 1971 Jun 20; 52(211):1025-34. PubMed ID: 5138331
    [No Abstract] [Full Text] [Related]

  • 6. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
    Marchettini G, Maggi P, Benvenuti C.
    Clin Ter; 1978 Sep 15; 86(5):485-94. PubMed ID: 367683
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of diphenoxy-acetic acid derivative on biliary and pancreatic secretions in rats].
    Debray C, Vaille C, De la Tour J, Roze C, Souchard M, Chariot J.
    Rev Int Hepatol; 1968 Sep 15; 18(6):785-98. PubMed ID: 5702102
    [No Abstract] [Full Text] [Related]

  • 9. [Odeston in treatment of chronic diseases of hepatobiliary system].
    Nasonova SV, Lebedeva OI.
    Voen Med Zh; 2001 Feb 15; 322(2):49-53. PubMed ID: 11338822
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [New therapeutic aspects in substitutive treatment with homologous and heterologous enzymes of gastro-entero-biliary hyposthenic diseases].
    Palmari V, Pietranera P.
    Clin Ter; 1970 May 31; 53(4):299-313. PubMed ID: 4918645
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of enzyme therapy on food tolerance and digestive disorders].
    Gullatz P.
    Landarzt; 1968 Nov 30; 44(33):1635-8. PubMed ID: 5717136
    [No Abstract] [Full Text] [Related]

  • 15. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
    Dehtiar'ova II, Chernenko VV, Anokhina HA, Opanasiuk ND, Pavlik-Novol's'kyĭ T, Haĭsenko AV.
    Lik Sprava; 1995 Nov 30; (9-12):47-8. PubMed ID: 8983789
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Personal experiences in the treatment of bile duct diseases using Genebil].
    De Marcos Perez VM.
    Rev Esp Enferm Apar Dig; 1969 Nov 30; 29(4):569-84. PubMed ID: 5363141
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical classification of current choleretic preparations].
    Skakun NP.
    Vrach Delo; 1965 Aug 30; 8():26-9. PubMed ID: 5870987
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.